Showing 2471-2480 of 3134 results for "".
- First-ever Data on Vaginal Regeneration for ThermiVahttps://modernaesthetics.com/news/first-ever-data-on-vaginal-regeneration-for-thermiva/2472081/Thermi’s ThermiVa® device has been shown to deliver significant improvements in common vaginal disorders and improve sexual satisfaction, according to a study published in Dermatologic Surgery. Since it was cleared by the FDA in 2013, ThermiVa has been used in more t
- InMode Launches Embrace RF Facial Contouring Solutionhttps://modernaesthetics.com/news/inmode-launches-embrace-rf-facial-contouring-solution/2472082/InMode Aesthetic Solutions is introducing EmbraceRF to target the neck and face through a powerful combination of InMode’s proprietary technologies: FaceTite and Morpheus8. InMode says the new facial contouring solution address a tr
- Revance Vet Tapped as New Evolus CFOhttps://modernaesthetics.com/news/revance-vet-tapped-as-new-evolus-cfo/2472086/Lauren Silvernail is the new Chief Financial Officer and Executive Vice President, Corporate Development at Evolus, Inc. Silvernail joins Evolus from Revance Therapeutics where she most recently served as Chief Financial Officer and Chief Business Officer. Prior to her time at Revance The
- Restylane Lyft Now FDA-Approved for Handshttps://modernaesthetics.com/news/restylane-lyft-now-fda-approved-for-hands/2472088/The US Food and Drug Administration has approved Restylane Lyft for use on the dorsal hands of people older then 21, making it the first hyaluronic acid (HA) injectable gel approved for this use. Radiesse (Calcium Hydroxylapatite) is also approved for the correction of lost
- FDA Says No to Evolus' Botox Rivalhttps://modernaesthetics.com/news/fda-says-no-to-evolus-botox-rival/2472089/The U.S Food and Drug Administration did not approve DWP-450, Evolus Inc's rival product to Allergan Plc's Botox, due to chemistry and manufacturing issues. As a result, the company pushed its estimate for the launch of the drug to the spring of next year. Read more
- Sciton Names New Leadership Teamhttps://modernaesthetics.com/news/sciton-names-new-leadership-team/2472093/Sciton has an all new leadership team. The new Sciton leaders are: Aaron Burton, Chief Operating Officer Todd Sternbach, Vice President of Strategic Sales Initiatives David Percival, Vice President / General Manager of Sciton Intern
- Jury Still Out on Cosmetic Uses of PRPhttps://modernaesthetics.com/news/more-research-needed-on-cosmetic-uses-of-prp/2472097/Most studies evaluating platelet-rich plasma (PRP) injection for facial rejuvenation and other cosmetic procedures have reported positive results
- New Line of Laser Systems Now Available from Sensus Healthcarehttps://modernaesthetics.com/news/new-line-of-lasers-systems-now-available-from-sensus-healthcare/2472120/Sensus Healthcare, Inc. has launched Sensus Laser Systems, a unique multi-platform line of high-quality, cost-effective lasers for hair and tattoo removal, acne lesion correction, skin rejuvenation and pigmentation/large pore treatment. Prior to this launch, the medical device company specialized
- FDA OKs Describe Patch for Use with All Tattoo Removal Lasershttps://modernaesthetics.com/news/fda-oks-describe-patch-for-use-with-all-tattoo-removal-lasers/2472158/Merz North America’s DESCRIBE® PFD Patch is now cleared by the Food and Drug Administration (FDA) for all commonly used lasers for tattoo removal. The new FDA c
- Fat Reduction Following Treatment with BTL Vanquish Lasts Four Yearshttps://modernaesthetics.com/news/fat-reduction-following-treatment-with-btl-vanquish-lasts-four-years/2472169/Abdominal fat reduction achieved via BTL Vanquish and Vanquish ME lasts for at least four years, according to new long-term data released